European Academy of Allergy and Clinical Immunology | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 599,581 条关于 “European Academy of Allergy and Clinical Immunology”

KalVista's Sebetralstat Advances Toward Potential Approval for Hereditary Angioedema

Novel Grass Pollen Immunotherapy Shows Superior 20.3% Symptom Reduction in Landmark Phase 3 Trial

Stallergenes Greer to Present Paediatric Phase III YOBI Data and Real-World EfficAPSI Findings at EAACI 2026

Stallergenes Greer's Staloral Birch Achieves Primary Endpoint in Pediatric Phase III Trial for Allergic Rhinoconjunctivitis

Celltrion Launches 300 mg Omlyclo Omalizumab Biosimilar Across Key European Markets

Jasper Therapeutics to Present Briquilimab Clinical Data at EAACI Congress 2025

PRT120 Peanut Oral Immunotherapy Demonstrates Durable 3-Year Remission in Phase 2b Study

Professor Mohamed Shamji Assumes EAACI Presidency as Congress 2026 Concludes with Vision Zero Momentum

Intellia's CRISPR Gene Therapy Shows 98% Reduction in HAE Attacks After Three Years

Donidalorsen Shows 62% Reduction in HAE Attacks When Patients Switch from Other Prophylactics in Phase 3 Study

第 1 页，共 4083 页